Real-world clinical effectiveness and exploratory longitudinal immunological changes of Efgartigimod in myasthenia gravis: a retrospective study and a single-cell analysis in one patient.

Tian L, Zhang L, Jin J, Wang X, Chen Z, Qiao L, Guo Q, Li Y, Zhang J, Zhao Y, Wang L, Li L, Wang J

Open source

DOI
10.3389/fneur.2026.1980412
Published
2026
Container
Frontiers in neurology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1980412,
  title = {Real-world clinical effectiveness and exploratory longitudinal immunological changes of Efgartigimod in myasthenia gravis: a retrospective study and a single-cell analysis in one patient.},
  author = {Tian L and Zhang L and Jin J and Wang X and Chen Z and Qiao L and Guo Q and Li Y and Zhang J and Zhao Y and Wang L and Li L and Wang J},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1980412},
  url = {https://doi.org/10.3389/fneur.2026.1980412}
}

RIS

TY  - JOUR
TI  - Real-world clinical effectiveness and exploratory longitudinal immunological changes of Efgartigimod in myasthenia gravis: a retrospective study and a single-cell analysis in one patient.
AU  - Tian L
AU  - Zhang L
AU  - Jin J
AU  - Wang X
AU  - Chen Z
AU  - Qiao L
AU  - Guo Q
AU  - Li Y
AU  - Zhang J
AU  - Zhao Y
AU  - Wang L
AU  - Li L
AU  - Wang J
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1980412
UR  - https://doi.org/10.3389/fneur.2026.1980412
ER  - 

APA

L, T., L, Z., J, J., X, W., Z, C., L, Q., Q, G., Y, L., J, Z., Y, Z., L, W., L, L., & J, W. (2026). Real-world clinical effectiveness and exploratory longitudinal immunological changes of Efgartigimod in myasthenia gravis: a retrospective study and a single-cell analysis in one patient.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1980412

Source records